Disease activity after natalizumab discontinuation in multiple sclerosis: reactivation or rebound?

被引：0
|
作者：
Borriello, G. [1 ]
Prosperini, L. [1 ]
Mancinelli, C. [1 ]
Fubelli, F. [1 ]
Gianni, C. [1 ]
Marinelli, F. [1 ]
Pozzilli, C. [1 ]
机构：
[1] S Andrea Hosp, Rome, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P529
引用
收藏
页码：S228 / S228
页数：1
相关论文
共 50 条
  • [21] Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia
    Loredana La Mantia
    Valentina Prone
    Maria Raffaella Marazzi
    Cristina Erminio
    Alessandra Protti
    Neurological Sciences, 2014, 35 : 1485 - 1486
  • [22] Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia
    La Mantia, Loredana
    Prone, Valentina
    Marazzi, Maria Raffaella
    Erminio, Cristina
    Protti, Alessandra
    NEUROLOGICAL SCIENCES, 2014, 35 (09) : 1485 - 1486
  • [23] Catastrophic rebound after natalizumab treatment discontinuation
    Gonzalez Suarez, I.
    Orviz, A.
    Matias-Guiu, J.
    Valencia, C.
    Moreno-Garcia, S.
    Valle-Arcos, M. D.
    Rodriguez de Antonio, L.
    Jorquera-Moya, M.
    Oreja-Guevara, C.
    JOURNAL OF NEUROLOGY, 2014, 261 : S304 - S304
  • [24] Catastrophic rebound after natalizumab treatment discontinuation
    Gonzalez Suarez, I.
    Orviz, A.
    Matias-Guiu, J.
    Valencia, C.
    Moreno-Garcia, S.
    Valle-Arcos, M. D.
    Rodriguez de Antonio, L.
    Jorquera-Moya, M.
    Oreja-Guevara, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 458 - 458
  • [25] Disease activity return after natalizumab cessation in multiple sclerosis
    Rasenack, Maria
    Derfuss, Tobias
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 587 - 594
  • [26] Rebound Disease Activity Reduction in Relapsing Multiple Sclerosis Patients Transitioned From Natalizumab to Teriflunomide
    Cohan, Stanley
    Edwards, Keith R.
    Chen, Chiayi
    Gervasi, Tiffany
    O'Connor, Judy
    Smoot, Kyle
    Kresa-Reahl, Kiren
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 70 - 70
  • [27] Rebound disease activity reduction in relapsing multiple sclerosis patients transitioned from natalizumab to teriflunomide
    Cohan, S.
    Edwards, K.
    Chen, C.
    Gervasi, T.
    O'Connor, J.
    Smoot, K.
    Kresa-Reahl, K.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 313 - 313
  • [28] Pseudotumoral rebound of multiple sclerosis in a pregnant patient after stopping natalizumab
    Verhaeghe, Alexander
    Deryck, Olivier Maurice
    Vanopdenbosch, Ludo J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (02) : 279 - 281
  • [29] The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis
    Coerver, E.
    Schoof, L.
    Hogenboom, L.
    Wessels, M.
    van Ruyven, P.
    van Samkar, A.
    Mostert, J.
    van Kempen, Z.
    van Oosten, B. W.
    Wokke, B. H.
    Tallantyre, E.
    Myhr, K. M.
    Torkildsen, O.
    Killestein, J.
    Smets, I.
    Strijbis, E.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 91
  • [30] The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis
    Coerver, Eline
    Schoof, Lisa
    Hogenboom, Laura
    Wessels, Mark
    van Ruyven, Paula
    van Samkar, Anusha
    Mostert, Jop
    van Kempen, Zoe
    van Oosten, Bob
    Wokke, Beatrijs
    Tallantyre, Emma
    Myhr, Kjell-Morten
    Torkildsen, Oivind
    Killestein, Joep
    Smets, Ide
    Strijbis, Eva
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1063 - 1064
12345